欧莱雅集团宣布投资中国领先生物技术初创企业未名拾光

Core Insights - L'Oréal Group announced a strategic partnership with Chinese biotech company Veminsyn on May 23, involving a minority equity investment [1] - The collaboration aims to co-develop innovative bioactive ingredients and promote their large-scale production using low-carbon biomanufacturing technologies for cosmetic raw materials [1] - This investment is part of L'Oréal China's latest open innovation initiative, supported by the BOLD (Business Opportunities for L'Oréal Development) strategic innovation venture capital fund [1] - Veminsyn is recognized as a winning company in the 2023 "L'Oréal BIG BANG Beauty Tech Co-Creation Program" [1]